2025 Elevance eases investor concerns with better-than-feared quarterly profit Elevance Health on Thursday posted a better-than-feared fourth-quarter profit, which came as a relief to investors ...

In a regulatory filing, Elevance Health (ELV) disclosed that its officers will speak with investors over the next several weeks. During these ...

Sravanthi Kalapati, a healthcare data engineering, artificial intelligence, and machine learning leader at Elevance Health, ...

Many stock analysts see Indianapolis-based Elevance’s recent struggles as an opportunity. Thirteen of 24 analysts tracked by The Wall Street Journal rate the health insurer as a buy.

With its stock down 7.4% over the past three months, it is easy to disregard Elevance Health (NYSE:ELV). However, stock prices are usually driven by a company’s financial performance over the ...

Elevance Health Inc. closed 30.74% short of its 52-week high of $567.26, which the company reached on September 3rd.